These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Interaction between panel reactive antibodies, auto- and cold reactive antibodies, and a positive B cell cross-match in renal and cardiac allograft survival. Creemers P; Brink J; Kahn D Clin Transplant; 1997 Apr; 11(2):134-8. PubMed ID: 9113450 [TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of complement-fixing antibodies in cardiac transplantation. Rose ML; Smith JD Hum Immunol; 2009 Aug; 70(8):605-9. PubMed ID: 19375471 [TBL] [Abstract][Full Text] [Related]
7. Effect of HLA matching in heart transplantation. Collaborative Heart Transplant Study. Opelz G Transplant Proc; 1989 Feb; 21(1 Pt 1):794-6. PubMed ID: 2650297 [No Abstract] [Full Text] [Related]
8. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies. Bućin D; Johansson S; Lindberg LO Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800 [TBL] [Abstract][Full Text] [Related]
9. Anti-HLA antibodies and heart allograft survival. Fenoglio J; Ho E; Reed E; Rose E; Smith C; Reemstma K; Marboe C; Suciu-Foca N Transplant Proc; 1989 Feb; 21(1 Pt 1):807-9. PubMed ID: 2650277 [No Abstract] [Full Text] [Related]
10. Influence of donor-recipient lymphocyte crossmatch and ABO status on rejection risk in cardiac transplantation. McKenzie FN; Tadros N; Stiller C; Keown P; Sinclair N; Kostuk W Transplant Proc; 1987 Aug; 19(4):3439-41. PubMed ID: 3303513 [No Abstract] [Full Text] [Related]
13. The feasibility of HLA matching for lung transplantation. McGee C; Fox MD; Loyd JE Clin Transplant; 1996 Dec; 10(6 Pt 1):564-7. PubMed ID: 8996780 [TBL] [Abstract][Full Text] [Related]
14. Corneal transplantation: a single center experience 1976 to 1988. Völker-Dieben HJ; D'Amaro J Clin Transpl; 1988; ():249-61. PubMed ID: 3154477 [No Abstract] [Full Text] [Related]
15. [HLA-compatibility testing in kidney transplantation--past, present and future]. van Rood JJ; Persijn GG; van Leeuwen A; Goulmy E; Lansbergen Q; Cohen B Chirurg; 1980 May; 51(5):257-62. PubMed ID: 6447582 [No Abstract] [Full Text] [Related]
16. The clinical relevance of HLA matching in heart transplantation: impact on rejection and donor-directed cytotoxicity of graft infiltrating lymphocytes. Baan CC; Ouwehand AJ; Vaessen LM; Jutte NH; Balk AH; Mochtar B; Claas FH; Weimar W Transplant Proc; 1991 Oct; 23(5):2670-1. PubMed ID: 1926527 [No Abstract] [Full Text] [Related]
17. Successful transplantation after conversion of a positive crossmatch to negative by dissociation of IgM antibody. Louis P; Senitzer D; Tellis VA; Matas AJ Transplant Proc; 1989 Feb; 21(1 Pt 1):764-5. PubMed ID: 2650262 [No Abstract] [Full Text] [Related]
18. Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching. Reinhard T; Böhringer D; Enczmann J; Kögler G; Mayweg S; Wernet P; Sundmacher R Eye (Lond); 2004 Mar; 18(3):269-77. PubMed ID: 15004576 [TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of antibodies to HLA antigens undetectable by the standard complement-dependent cytotoxicity test. Slavcev A; Lácha J; Honsová E; Sajdlová H; Lodererová A; Vítko S; Valhová S; Stríz I; Ivasková E Transpl Int; 2003 Dec; 16(12):872-8. PubMed ID: 12904845 [TBL] [Abstract][Full Text] [Related]
20. Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study. Opelz G; Döhler B; Süsal C Hum Immunol; 2009 Aug; 70(8):627-30. PubMed ID: 19375469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]